Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke...

32
Acute Ischemic Stroke: Time vs Tissue Greg Albers, MD Coyote Foundation Professor of Neurology and Neurological Sciences Stanford University School of Medicine Director, Stanford Stroke Center Stanford University Medical Center

Transcript of Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke...

Page 1: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Acute Ischemic Stroke: Time vs Tissue

Greg Albers, MDCoyote Foundation Professor of Neurology and Neurological Sciences

Stanford University School of MedicineDirector, Stanford Stroke Center

Stanford University Medical Center

Page 2: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Stroke Treatment in 2010

Problem: very few stroke patients receive treatment (5%)

Two treatments FDA approved:Intravenous tPA – treatment must begin <3-4.5 hrsMechanical devices; FDA approval but not clear who benefits and effective time window

Page 3: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Advances in Stroke Imaging:Expanding the window for stroke therapy

Page 4: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

The Mismatch Concept

Core(dead)

Penumbra(salvageable)

• Infarct Core (game over):

Diffusion Weighted MRI (DWI)

• Penumbra or salvageable:

Perfusion Weighted MRI (PWI)

• Mismatch ratio:

Penumbra/Core

Page 5: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

The Mismatch Concept

Penumbra(salvageable)

Core(dead)

Page 6: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE Study

DWI / PWIEvaluation For Understanding Stroke Evolution

Page 7: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

6 hrsStroke score

16

PWI: 95 cc ↓ FlowDWI: 3 cc

4.5 hoursafter t–PA

Stroke score 5

6 cc Improved0 cc

Benefit of t-PA At 6 hrs in Mismatch Patients

Page 8: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

215 cc vessel occlusion105 cc

Beforet–PA

> 100 cc vessel open 77 cc

4 hoursafter t–PA

The Malignant Mismatch – t-PA Harmful

Page 9: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Image Analysis

MR tech pushes DWI & PWI to

RAPID

Auto-send

Stroke MRI or CT 00:00Completion of scan

04:30RAPID image analysis complete

05:00Images on PACS

Automated Image Processing Required: RAPID Software

00:30image arrival

Page 10: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE 2 Protocol

MRIbaseline

Intra-arterial Therapy

MRIPost-procedure

(reperfusion)

MRIDay 5

(infarct volume)

Favorable clinical response:•NIHSS score of 0-1 at day 30 orimprovement of NIHSS score by ≥8 points between baseline and day 30

Page 11: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

88-Year-Old Female - IV t-PA Not Effective

Page 12: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

After mechanical clot removal

Complete neurologic recovery at 24 hrs

After Mechanical Clot Removal

Page 13: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Use of Imaging to Monitor Stroke Therapies

Page 14: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

79 yo female, left side paralysis

CT Perfusion at 6.5 hours

Page 15: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Blocked Artery Open at 8 Hours

Angiogram pre and post mechanical device

No blood flow to parts of brain Restored blood flow

Clot

Page 16: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Blocked Artery Open at 8 Hours

Angiogram pre and post mechanical device

No blood flow to parts of brain Restored blood flow

Clot

Page 17: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 16 hours

Page 18: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 16 hours

Tmax at 16 hours

Page 19: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 3 days

DWI at 16 hours

Page 20: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

88-Year-Old Female - IV t-PA Not Effective

Page 21: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15Mean Tmax 4s

61-Yr-Old, 7 hrs After Left Side Paralysis

Page 22: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Recanalization at 6 hours after onset

Page 23: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Baseline PWI lesion=153 cc

Early follow-up PWI lesion=45 cc

Final stroke size= 45 cc

Page 24: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Tissue vs. Time

Page 25: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

62 yo male 2.5 hrs after symptom onset- CT PERFUSION

Page 26: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment
Page 27: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15 Mean Tmax 4s

82 yo female, iv tpa not effective, severe stroke symptoms

Page 28: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Carotid artery open at 4 hours

Page 29: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15 Mean Tmax 4s

Follow-up MRI 4 hours later (8 after onset). Full recovery

Page 30: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Baseline DWI lesion= 10 cc; NIH 22

Day 3: 5 cc

Baseline PWI lesion

Day 3: Flair lesion = 11 cc; NIH 0

Page 31: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

How to Increase theEffectiveness of Stroke Treatment:

• Use advanced imaging to triage and monitor therapy

• Don’t treat patients with severe irreversible damage

• Treat patients with salvageable tissue even if they arrive late

• Use intravenous tPA for small clots; mechanical devices for large clots

Page 32: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE 2 Coordinating Center

R. Bammer

M. MoseleyM. Mlynash

M. Marks

S. Kemp

J.M. Olivot

M. Straka

A. Purushotham

M. Lansberg